The EU Joint Programme – Neurodegenerative Disease Research (JPND) has launched the 2019 joint trans-national call for multinational research projects on ‘Personalised Medicine for Neurodegenerative Diseases’, with a pre-proposal deadline of 12 March 2019.
The FNR supports this Call through its INTER programme and will contribute up to 500,000 EUR, which is expected to fund up to 2 projects. Luxembourg is among 20 countries participating in this Call.
JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics together with environmental and lifestyle factors.
Tackling Parkinson’s disease is also a priority identified and supported by the FNR, most notably through NCER-PD, a national centre of excellence in research in Parkinson’s Disease. NCER-PD launched in 2015, with an 8 MEUR FNR grant for the first 4 years of the study.
On Monday, 14 January 2019, the FNR hosted an info session to inform about multilateral Calls in the biomedical domain, supported by the FNR via the INTER programme.